Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie Inc.    ABBV

ABBVIE INC.

(ABBV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

ABBVIE INC. : Ex-dividend day for

10/14/2020 EST

A dividend is removed today from AbbVie Inc.'s share.



© Factset 2020
All news about ABBVIE INC.
12/02ABBVIE : Working With Frontier Medicines to Develop Therapeutics
DJ
12/02ABBVIE : and Frontier Medicines Establish Global Partnership to Discover and Dev..
PR
12/02FRONTIER MEDICINES : and AbbVie Establish Global Partnership to Discover and Dev..
PR
12/01ABBVIE : to Host Virtual Immunology Strategic Update
PR
11/25ABBVIE : to Present at the Evercore ISI Conference and Piper Sandler Healthcare ..
AQ
11/24ABBVIE : to Present at the Evercore ISI Conference and Piper Sandler Healthcare ..
PR
11/19ABBVIE : Announces Expiration and Final Results of Registered Exchange Offers
AQ
11/18ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
11/18ABBVIE : Announces Expiration and Final Results of Registered Exchange Offers
PR
11/18Berkshire's bet a bright spot in gloomy year for Big Pharma stocks
RE
More news
Financials (USD)
Sales 2020 45 620 M - -
Net income 2020 12 365 M - -
Net Debt 2020 74 496 M - -
P/E ratio 2020 25,6x
Yield 2020 4,51%
Capitalization 185 B 185 B -
EV / Sales 2020 5,69x
EV / Sales 2021 4,61x
Nbr of Employees 47 000
Free-Float 98,5%
Chart ABBVIE INC.
Duration : Period :
AbbVie Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ABBVIE INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Average target price 111,64 $
Last Close Price 104,74 $
Spread / Highest target 21,3%
Spread / Average Target 6,58%
Spread / Lowest Target -7,39%
EPS Revisions
Managers
NameTitle
Richard A. Gonzalez Chairman & Chief Executive Officer
Michael E. Severino Vice Chairman & President
Azita Saleki-Gerhardt Executive Vice President-Operations
Robert A. Michael Chief Financial Officer & Executive Vice President
Thomas J. Hudson Chief Scientific Officer, Senior VP-R&D
Sector and Competitors
1st jan.Capitalization (M$)
ABBVIE INC.18.30%184 916
JOHNSON & JOHNSON2.15%392 249
ROCHE HOLDING AG-4.55%287 762
PFIZER, INC.8.00%222 836
NOVARTIS AG-11.95%206 585
MERCK & CO., INC.-10.45%206 071